EdgePoint Investment Group Inc. Invests $172.14 Million in Thermo Fisher Scientific Inc. $TMO

Key Points

• EdgePoint Investment Group Inc. has acquired a new stake in Thermo Fisher Scientific, purchasing 345,938 shares valued at approximately $172 million, making it the company's 22nd largest holding.
• Insider selling has been reported, including transactions by CAO Joseph R. Holmes and EVP Gianluca Pettiti, with nearly 30,000 shares sold by insiders in the last 90 days.
• Thermo Fisher Scientific recently announced a quarterly dividend of $0.43 per share, scheduled for payment on October 15th, representing an annual yield of 0.4%.

EdgePoint Investment Group Inc. acquired a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 345,938 shares of the medical research company's stock, valued at approximately $172,139,000. Thermo Fisher Scientific makes up 1.4% of EdgePoint Investment Group Inc.'s portfolio, making the stock its 22nd largest holding. EdgePoint Investment Group Inc. owned about 0.09% of Thermo Fisher Scientific at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Bernard Wealth Management Corp. acquired a new position in Thermo Fisher Scientific in the fourth quarter worth about $25,000. Ameriflex Group Inc. acquired a new position in Thermo Fisher Scientific in the fourth quarter worth about $30,000. Keystone Global Partners LLC acquired a new position in Thermo Fisher Scientific in the first quarter worth about $31,000. IMA Advisory Services Inc. acquired a new position in Thermo Fisher Scientific in the first quarter worth about $35,000. Finally, Smallwood Wealth Investment Management LLC acquired a new stake in shares of Thermo Fisher Scientific during the first quarter worth $37,000. Institutional investors own 89.23% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on TMO shares. Robert W. Baird increased their target price on shares of Thermo Fisher Scientific from $553.00 to $567.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Raymond James Financial reissued an "outperform" rating and set a $535.00 target price (up from $525.00) on shares of Thermo Fisher Scientific in a report on Thursday, July 24th. Wall Street Zen cut shares of Thermo Fisher Scientific from a "buy" rating to a "hold" rating in a report on Sunday. William Blair started coverage on shares of Thermo Fisher Scientific in a report on Monday, August 18th. They set an "outperform" rating on the stock. Finally, Scotiabank raised shares of Thermo Fisher Scientific from a "sector perform" rating to a "sector outperform" rating and set a $590.00 target price on the stock in a report on Friday, July 11th. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, Thermo Fisher Scientific currently has an average rating of "Moderate Buy" and an average price target of $589.38.

Insider Buying and Selling

In related news, CAO Joseph R. Holmes sold 385 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $492.63, for a total value of $189,662.55. Following the transaction, the chief accounting officer owned 2,319 shares of the company's stock, valued at approximately $1,142,408.97. This trade represents a 14.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Marc N. Casper sold 10,000 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $500.96, for a total value of $5,009,600.00. Following the completion of the transaction, the chief executive officer directly owned 115,174 shares in the company, valued at $57,697,567.04. This represents a 7.99% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 29,666 shares of company stock valued at $13,982,763. 0.33% of the stock is owned by corporate insiders.

Thermo Fisher Scientific Price Performance

Thermo Fisher Scientific stock traded up $2.71 during midday trading on Friday, hitting $492.20. The company's stock had a trading volume of 1,442,575 shares, compared to its average volume of 1,624,930. The company has a quick ratio of 1.50, a current ratio of 1.93 and a debt-to-equity ratio of 0.65. The stock's 50-day moving average price is $460.72 and its 200-day moving average price is $452.89. Thermo Fisher Scientific Inc. has a 12 month low of $385.46 and a 12 month high of $627.88. The company has a market capitalization of $185.86 billion, a PE ratio of 28.47, a price-to-earnings-growth ratio of 2.63 and a beta of 0.75.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.22 by $0.14. The firm had revenue of $10.86 billion for the quarter, compared to analyst estimates of $10.68 billion. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The firm's quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.37 earnings per share. Thermo Fisher Scientific has set its Q3 2025 guidance at 5.460-5.510 EPS. FY 2025 guidance at 22.220-22.840 EPS. Analysts anticipate that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Monday, September 15th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $1.72 dividend on an annualized basis and a yield of 0.3%. Thermo Fisher Scientific's dividend payout ratio (DPR) is currently 9.95%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.